Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.

Authors :: Cosma S
Carosso AR
Corcione S
Cusato J
Borella F
Antonucci M
Marozio L
Revelli A
Preti M
Ghisetti V
Di Perri G
Benedetto C
Source :: Journal of reproductive immunology [J Reprod Immunol] 2021 Apr; Vol. 144, pp. 103285. Date of Electronic Publication: 2021 Feb 02.
Publication Year :: 2021
Abstract: We report herein the longest-lasting study of SARS-CoV-2 antibody profile in pregnancy, from first trimester-infection to delivery. Seventeen out of 164 pregnant women tested positive for COVID-19. Throughout pregnancy, the neutralizing antibody titer remained stable, whilst a significant decline in the non-neutralizing antibodies was observed after 16 weeks of gestation. All the newborns of women who developed IgG antibodies showed the presence of the same antibodies in arterial cord blood. Knowledge on the longevity and type of SARS-CoV-2 antibody response may help to guide vaccination strategies in pregnancy.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)

Subjects :: Adult
Antibodies, Viral immunology
COVID-19 immunology
Female
Humans
Immunoglobulin G immunology
Longitudinal Studies
Pregnancy
Pregnancy Complications, Infectious immunology
SARS-CoV-2 immunology
Antibodies, Neutralizing blood
Antibodies, Viral blood
COVID-19 blood
Immunoglobulin G blood
Pregnancy Complications, Infectious blood
SARS-CoV-2 metabolism

Full Text Access

Tools